位置:成果数据库 > 期刊 > 期刊详情页
微小RNA-382在肾小管间质纤维化发病中的作用及其分子机制
  • ISSN号:1001-7097
  • 期刊名称:《中华肾脏病杂志》
  • 时间:0
  • 分类:R692[医药卫生—泌尿科学;医药卫生—临床医学;医药卫生—外科学]
  • 作者机构:[1]复旦大学附属中山医院肾内科上海市肾脏疾病与血液净化重点实验室上海市肾病与透析研究所,上海200032
  • 相关基金:国家自然科学基金(81200557);上海市科委科研计划项目(14DZ2260200)
中文摘要:

目的 研究微小RNA-382(miR-382)在肾小管间质纤维化(TIF)发病中的作用及相关机制.方法 通过抑制miR-382的表达,观察其丰度对人近端肾小管上皮细胞(HK2)转分化的影响,并验证miR-382与其预测靶基因热休克蛋白60(HSPD1)的互补配对关系.建立小鼠单侧输尿管梗阻(UUO)模型,经尾静脉注射锁核苷酸(LAN)修饰的anti-miR-382,观察抑制miR-382表达对梗阻侧肾小管间质病变及肾组织硫氧还原蛋白(Trx)水平的影响.收集有和无明显TIF的IgA肾病(IgAN)患者肾穿刺标本各6例,原位杂交和免疫组化法检查TIF程度及抗氧化应激水平,分析其与miR-382/HSPD1表达的相关性.结果 体外荧光素酶报告基因检测和定点突变实验结果证实HSPD1为新的miR-382对应的直接靶基因.TGF-β1诱导HK2细胞发生转分化,与对照组相比,TGF组miR-382表达水平显著上调[(6.54±0.96)比(1.12±0.26),P< 0.05];阻断miR-382可使TGF-β1诱导的上皮转分化部分被逆转.体内实验结果表明,UUO模型组小鼠发生明显TIF病变,与假手术组相比,模型组miR-382丰度明显上调[(6.89±2.47)比(1.00±0.42),P< 0.05],HSPD1和Trx蛋白表达水平明显下调.10 mg/kg LNA-anti-miR-382干预组miR-382表达下调,梗阻侧肾组织TIF程度减轻,HSPD1和Trx的蛋白表达水平上调(均P< 0.05).IgAN患者肾组织检查结果提示,与无纤维化组相比,纤维化组肾组织miR-382丰度明显上调,HSPD1蛋白表达水平则明显降低(均P<0.05).结论 miR-382在人类及小鼠TIF发病中起重要作用,HSPD1是miR-382的直接靶基因.HSPD1表达下调导致相应的抗氧化应激能力减弱可能是miR-382参与TIF的机制之一.

英文摘要:

Objective To investigate the roles of microRNA-382 (miR-382) in the pathogenesis of renal tubulointerstitial fibrosis (TIF).Methods Human kidney epithelial cells (HK2)transfected with miR-382 inhibitor (antagomiR-382) were used to examine the effect of miR-382 abundance on cell polarity,as well as to test the complementary relationship between miR-382 and its predicted target gene heat shock protein 60 (HSPD1),which was further verified by 3'-untranslated region luciferase assay and site-directed mutagenesis.The role of miR-382 played in the development of renal interstitial fibrosis and redox regulation was examined in a mouse unilateral ureteral obstruction (UUO) model.Locked nucleic acid (LAN)-modified anti-miR-382 was intravenous delivered via tail vein 30 min prior to UUO,and repeated the dosage 24 h after the surgery.For clinical verification,renal biopsy specimens from 12 IgA nephropathy (IgAN) patients were collected,6 patients with moderate to severe TIF and 6 patients without TIF.The relative abundance of miR-382 and HSPD1 protein was analyzed by using in situ hybridization and immunohistochemistry.Results HSPD1 was confirmed to be a new,direct target gene of miR-382 by in vitro 3'-untranslated region luciferase assay and sitedirected mutagenesis.The development of epithelial transition in HK2 cells was accompanied with upregulation of miR-382 [(6.54±0.96) vs (1.12±0.26),P 〈 0.05].Blocking the expression of miR-382 could reversed the progression of epithelial transition partially.In UUO mice the abundance of miR-382 was up-regulated [(6.89 ± 2.47) vs (1.00±0.42),P 〈 0.01] while HSPD1 and Trx were downregulated compared with the sham group.Down-regulation of miR-382 was associated with significant decrease in TIF,but increase in HSPD1 and thioredoxin protein compared with UUO group [HSPD1:(0.34±0.10) vs (0.14±0.05);Trx:(0.79±0.18) vs (0.36±0.16);all P 〈 0.05].The expression of miR-382 was up-regulated and HSPD1 was sign

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中华肾脏病杂志》
  • 北大核心期刊(2011版)
  • 主管单位:中国科学技术协会
  • 主办单位:中华医学会
  • 主编:
  • 地址:广州市中山二路74号
  • 邮编:510089
  • 邮箱:cmaszb@mail.sysu.edu.cn
  • 电话:020-87331532
  • 国际标准刊号:ISSN:1001-7097
  • 国内统一刊号:ISSN:44-1217/R
  • 邮发代号:46-106
  • 获奖情况:
  • 国内外数据库收录:
  • 美国化学文摘(网络版),日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版),中国北大核心期刊(2000版)
  • 被引量:26419